| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.32 | 2e-08 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.28 | 3e-06 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.24 | 0.4 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.03 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.21 | 0.0008 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0008 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |